SHEELA JAYARAMAN Sheela.Jayaraman@nottingham.ac.uk
Professor of Cancer Biology and Gene Regulation
Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
Jayaraman, Padma Sheela; Gaston, Kevin
Authors
Professor KEVIN GASTON Kevin.Gaston@nottingham.ac.uk
Professor of Cancer Studies
Abstract
Cholangiocarcinoma (CCA) is a disease with a very poor prognosis and limited treatment options. Although targeted therapies directed towards specific mutations found in CCA are becoming available and are showing great potential, many tumors do not carry actionable mutations and, in those that do, the emergence of drug resistance is a likely consequence of treatment. Therapeutic targeting of enzymes and other proteins that show elevated activity in CCA cells but which are not altered by mutation is a potential strategy for the treatment of target negative and drug-resistant disease. Protein kinase CK2 (CK2) is a ubiquitously expressed kinase that has increased expression and increased activity in a variety of cancer types including CCA. Several potent CK2 inhibitors are in pre-clinical development or under assessment in a variety of clinical trials often in combination with drugs that induce DNA damage. This review outlines the importance of CK2 in CCA and assesses the progress that has been made in the evaluation of CK2 inhibition as a treatment strategy in this disease. Targeting CK2 based on the expression levels or activity of this protein and/or in combination with drugs that induce DNA damage or inhibit cell cycle progression, could be a viable option for tumors that lack actionable mutations, or for tumors that develop resistance to targeted treatments.
Citation
Jayaraman, P. S., & Gaston, K. (2021). Targeting protein kinase CK2 in the treatment of cholangiocarcinoma. Exploration of Targeted Anti-tumor Therapy, 2(5), 434-447. https://doi.org/10.37349/etat.2021.00055
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 31, 2021 |
Online Publication Date | Oct 9, 2021 |
Publication Date | Oct 31, 2021 |
Deposit Date | Nov 24, 2021 |
Publicly Available Date | Nov 26, 2021 |
Journal | Exploration of Targeted Anti-tumor Therapy |
Print ISSN | 2692-3114 |
Electronic ISSN | 2692-3114 |
Publisher | Open Exploration |
Peer Reviewed | Peer Reviewed |
Volume | 2 |
Issue | 5 |
Pages | 434-447 |
DOI | https://doi.org/10.37349/etat.2021.00055 |
Public URL | https://nottingham-repository.worktribe.com/output/6786586 |
Publisher URL | https://www.explorationpub.com/Journals/etat/Article/100255 |
Files
Targeting protein kinase CK2
(1.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Inhibition of Intimal Thickening By PRH (Proline-Rich Homeodomain) in Mice
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search